Expression of matrix metalloproteinase 9 (MMP-9) and tissue inhibitor of metalloproteinases 1 (TIMP-1) by colorectal cancer cells and adjacent stroma cells - Associations with histopathology and patients outcome

European Journal of Cancer

Volumn 46, Issue 18, 2010, Pages 3233-3242

  Jensen, Søren Astrup ^a   Vainer, Ben ^a   Bartels, Annette ^b   Brünner, Nils ^b   Sørensen, Jens Benn ^a  

^a Rigshospitalet   (Denmark)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

Biological; Colonic neoplasms; Disease free survival; Fluorouracil; Immunohistochemistry; Matrix metalloproteinase 9; Prognostic value of tests; Survival rate; Tissue inhibitor of metalloproteinases 1; Treatment outcome; Tumour markers

Indexed keywords

FLUOROURACIL; FOLINATE CALCIUM; GELATINASE B; TISSUE INHIBITOR OF METALLOPROTEINASE 1;

ARTICLE; CANCER CELL; CANCER INVASION; CANCER SURGERY; CARCINOMA CELL; CELL INTERACTION; COLORECTAL CANCER; CORRELATION ANALYSIS; DISEASE FREE SURVIVAL; FEMALE; FIBROBLAST; HISTOPATHOLOGY; HOST CELL; HUMAN; HUMAN TISSUE; IMMUNOREACTIVITY; LYMPHOCYTE; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; RETROSPECTIVE STUDY; STROMA CELL; TUMOR MICROENVIRONMENT;

ADULT; AGED; COLORECTAL NEOPLASMS; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MATRIX METALLOPROTEINASE 9; MICROSCOPY, ELECTRON; MIDDLE AGED; NEOPLASM METASTASIS; NEOPLASM PROTEINS; PROGNOSIS; STROMAL CELLS; TISSUE INHIBITOR OF METALLOPROTEINASE-1; TUMOR CELLS, CULTURED;

EID: 78649630590     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejca.2010.07.046     Document Type: Article

References (44)

1. S.A. Jensen, B. Vainer, M. Kruhoffer, and J.B. Sorensen Microsatellite instability in colorectal cancer and association with thymidylate synthase and dihydropyrimidine dehydrogenase expression BMC Cancer 9 2009 25
2. F. Roca, L.V. Mauro, and A. Morandi Prognostic value of E-cadherin, beta-catenin, MMPs (7 and 9), and TIMPs (1 and 2) in patients with colorectal carcinoma J Surg Oncol 93 2006 151 160
3. S. Curran, S.R. Dundas, and J. Buxton Matrix metalloproteinase/tissue inhibitors of matrix metalloproteinase phenotype identifies poor prognosis colorectal cancers Clin Cancer Res 10 2004 8229 8234
4. A. Moran, P. Iniesta, and C. Garcia-Aranda Clinical relevance of MMP-9, MMP-2, TIMP-1 and TIMP-2 in colorectal cancer Oncol Rep 13 2005 115 120
5. T. Takeuchi, M. Hisanaga, and M. Nagao The membrane-anchored matrix metalloproteinase (MMP) regulator RECK in combination with MMP-9 serves as an informative prognostic indicator for colorectal cancer Clin Cancer Res 10 2004 5572 5579
6. E.A. Baker, and D.J. Leaper The plasminogen activator and matrix metalloproteinase systems in colorectal cancer: relationship to tumour pathology Eur J Cancer 39 2003 981 988
7. E.T. Waas, R.M. Lomme, J. DeGroot, T. Wobbes, and T. Hendriks Tissue levels of active matrix metalloproteinase-2 and -9 in colorectal cancer Br J Cancer 86 2002 1876 1883
8. P. Ring, K. Johansson, M. Hoyhtya, K. Rubin, and G. Lindmark Expression of tissue inhibitor of metalloproteinases TIMP-2 in human colorectal cancer - a predictor of tumour stage Br J Cancer 76 1997 805 811
9. M. Murashige, M. Miyahara, and N. Shiraishi Enhanced expression of tissue inhibitors of metalloproteinases in human colorectal tumors Jpn J Clin Oncol 26 1996 303 309
10. Z.S. Zeng, A.M. Cohen, Z.F. Zhang, W. Stetler-Stevenson, and J.G. Guillem Elevated tissue inhibitor of metalloproteinase 1 RNA in colorectal cancer stroma correlates with lymph node and distant metastases Clin Cancer Res 1 1995 899 906
11. A. Sutnar, M. Pesta, and V. Liska Clinical relevance of the expression of mRNA of MMP-7, MMP-9, TIMP-1, TIMP-2 and CEA tissue samples from colorectal liver metastases Tumour Biol 28 2007 247 252
12. K. Guzinska-Ustymowicz MMP-9 and cathepsin B expression in tumor budding as an indicator of a more aggressive phenotype of colorectal cancer (CRC) Anticancer Res 26 2006 1589 1594
13. W.J. Lubbe, Z.Y. Zhou, and W. Fu Tumor epithelial cell matrix metalloproteinase 9 is a target for antimetastatic therapy in colorectal cancer Clin Cancer Res 12 2006 1876 1882
14. Y. Ogata, K. Matono, and T. Sasatomi The MMP-9 expression determined the efficacy of postoperative adjuvant chemotherapy using oral fluoropyrimidines in stage II or III colorectal cancer Cancer Chemother Pharmacol 57 2006 577 583
15. K. Saito, S. Takeha, and K. Shiba Clinicopathologic significance of urokinase receptor- and MMP-9-positive stromal cells in human colorectal cancer: functional multiplicity of matrix degradation on hematogenous metastasis Int J Cancer 86 2000 24 29
16. Z.S. Zeng, Y. Huang, A.M. Cohen, and J.G. Guillem Prediction of colorectal cancer relapse and survival via tissue RNA levels of matrix metalloproteinase-9 J Clin Oncol 14 1996 3133 3140
17. N.B. Liabakk, I. Talbot, R.A. Smith, K. Wilkinson, and F. Balkwill Matrix metalloprotease 2 (MMP-2) and matrix metalloprotease 9 (MMP-9) type IV collagenases in colorectal cancer Cancer Res 56 1996 190 196
18. M.G. Tutton, M.L. George, and S.A. Eccles Use of plasma MMP-2 and MMP-9 levels as a surrogate for tumour expression in colorectal cancer patients Int J Cancer 107 2003 541 550
19. K. Inuzuka, Y. Ogata, H. Nagase, and K. Shirouzu Significance of coexpression of urokinase-type plasminogen activator, and matrix metalloproteinase 3 (stromelysin) and 9 (gelatinase B) in colorectal carcinoma J Surg Res 93 2000 211 218
20. A.M. Langers, C.F. Sier, and L.J. Hawinkels MMP-2 geno-phenotype is prognostic for colorectal cancer survival, whereas MMP-9 is not Br J Cancer 98 2008 1820 1823
21. M.F. van der Jagt, F.C. Sweep, and E.T. Waas Correlation of reversion-inducing cysteine-rich protein with kazal motifs (RECK) and extracellular matrix metalloproteinase inducer (EMMPRIN), with MMP-2, MMP-9, and survival in colorectal cancer Cancer Lett 237 2006 289 297
22. S.L. Parsons, S.A. Watson, and H.M. Collins Gelatinase (MMP-2 and -9) expression in gastrointestinal malignancy Br J Cancer 78 1998 1495 1502
23. H. Islekel, G. Oktay, and C. Terzi Matrix metalloproteinase-9, -3 and tissue inhibitor of matrix metalloproteinase-1 in colorectal cancer: relationship to clinicopathological variables Cell Biochem Funct 25 2007 433 441
24. A. Moran, P. Iniesta, and C. De Juan Impairment of stromelysin-1 transcriptional activity by promoter mutations in high microsatellite instability colorectal tumors Cancer Res 65 2005 3811 3814
25. M. Hilska, P.J. Roberts, and Y.U. Collan Prognostic significance of matrix metalloproteinases-1, -2, -7 and -13 and tissue inhibitors of metalloproteinases-1, -2, -3 and -4 in colorectal cancer Int J Cancer 121 2007 714 723
26. M.N. Holten-Andersen, R.W. Stephens, and H.J. Nielsen High preoperative plasma tissue inhibitor of metalloproteinase-1 levels are associated with short survival of patients with colorectal cancer Clin Cancer Res 6 2000 4292 4299
27. A. Oberg, M. Hoyhtya, B. Tavelin, R. Stenling, and G. Lindmark Limited value of preoperative serum analyses of matrix metalloproteinases (MMP-2, MMP-9) and tissue inhibitors of matrix metalloproteinases (TIMP-1, TIMP-2) in colorectal cancer Anticancer Res 20 2000 1085 1091
28. H. Ishida, N. Murata, Y. Hayashi, M. Tada, and D. Hashimoto Serum levels of tissue inhibitor of metalloproteinases-1 (TIMP-1) in colorectal cancer patients Surg Today 33 2003 885 892
29. J.S. Rhee, R. Diaz, L. Korets, J.G. Hodgson, and L.M. Coussens TIMP-1 alters susceptibility to carcinogenesis Cancer Res 64 2004 952 961
30. C. Luparello, G. Avanzato, C. Carella, and I. Pucci-Minafra Tissue inhibitor of metalloprotease (TIMP)-1 and proliferative behaviour of clonal breast cancer cells Breast Cancer Res Treat 54 1999 235 244
31. G. Li, R. Fridman, and H.R. Kim Tissue inhibitor of metalloproteinase-1 inhibits apoptosis of human breast epithelial cells Cancer Res 59 1999 6267 6275
32. H. Liu, B. Chen, and B. Lilly Fibroblasts potentiate blood vessel formation partially through secreted factor TIMP-1 Angiogenesis 11 2008 223 234
33. Z.S. Zeng, and J.G. Guillem Colocalisation of matrix metalloproteinase-9- mRNA and protein in human colorectal cancer stromal cells Br J Cancer 74 1996 1161 1167
34. Z.S. Zeng, and J.G. Guillem Distinct pattern of matrix metalloproteinase 9 and tissue inhibitor of metalloproteinase 1 mRNA expression in human colorectal cancer and liver metastases Br J Cancer 72 1995 575 582
35. N.C. Gallegos, C. Smales, F.J. Savage, R.M. Hembry, and P.B. Boulos The distribution of matrix metalloproteinases and tissue inhibitor of metalloproteinases in colorectal cancer Surg Oncol 4 1995 21 29
36. M. Illemann, N. Bird, and A. Majeed MMP-9 is differentially expressed in primary human colorectal adenocarcinomas and their metastases Mol Cancer Res 4 2006 293 302
37. K.J. Heppner, L.M. Matrisian, R.A. Jensen, and W.H. Rodgers Expression of most matrix metalloproteinase family members in breast cancer represents a tumor-induced host response Am J Pathol 149 1996 273 282
38. V. Karavasilis, V. Malamou-Mitsi, and E. Briasoulis Matrix metalloproteinases in carcinoma of unknown primary Cancer 104 2005 2282 2287
39. I.V. Sorensen, C. Fenger, and H. Winther Characterization of anti-TIMP-1 monoclonal antibodies for immunohistochemical localization in formalin-fixed, paraffin-embedded tissue J Histochem Cytochem 54 2006 1075 1086
40. E.A. Baker, F.G. Bergin, and D.J. Leaper Matrix metalloproteinases, their tissue inhibitors and colorectal cancer staging Br J Surg 87 2000 1215 1221
41. A. Buhmeida, R. Bendardaf, and M. Hilska Prognostic significance of matrix metalloproteinase-9 (MMP-9) in stage II colorectal carcinoma J Gastrointest Cancer 40 2009 91 97
42. D. Unsal, N. Akyurek, and A. Uner Gelatinase B expression as a prognostic factor in patients with stage II/III rectal carcinoma treated by postoperative adjuvant therapy Am J Clin Oncol 31 2008 55 63
43. H. Ohtani Stromal reaction in cancer tissue: pathophysiologic significance of the expression of matrix-degrading enzymes in relation to matrix turnover and immune/inflammatory reactions Pathol Int 48 1998 1 9
44. N.M. Sorensen, A.S. Schrohl, and V. Jensen Comparative studies of tissue inhibitor of metalloproteinases-1 in plasma, serum and tumour tissue extracts from patients with primary colorectal cancer Scand J Gastroenterol 43 2008 186 191